Search - tctmd.com

Displaying 781 - 800 of 807

Sort: Relevancy | Date

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Presenter: Francisco Moniche

July 06, 2012

Presentation

Silent Cerebral Infarcts After Cardiac Catheterization

Presenter: Martial Hamon

June 26, 2012

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Presentation TVT 2012

Left Atrial Appendage Anatomy: An Anatomical Imaging Review and Implications for Stroke Prevention

Presenter: Rebecca Hahn

June 05, 2012

Presentation

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: S. Lee

June 05, 2012

Presentation TVT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Josep Rodes-Cabau

June 04, 2012

Presentation TVT 2012

Minimizing and Managing Stroke Risks

Presenter: Samir Kapadia

June 03, 2012

Presentation

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Presenter: Stefan K. James

May 31, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

Presentation

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

Presenter: James Grotta

May 02, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

Presentation

Intra Cranial Cases: Where, When, Who?

Presenter: Christopher J. White

May 01, 2012

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Presenter: Corrado Tamburino

April 25, 2012

Presentation

Volumen de Intervenciones Neuroquirúrgicas por Hospital en EE.UU.

Presenter: 202444|M Grigoryan

March 16, 2012

Presentation

Neurointerventional Procedural Volume Per Hospital in United States

Presenter: Mikayel Grigoryan

March 15, 2012

Presentation

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Presenter: Anthony J. Furlan

March 14, 2012

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

Presentation

Procedural Factors Associated with PCI-Related Ischemic Stroke

Presenter: S. Hoffman

February 29, 2012

Presentation

Resultados Primarios del Dispositivo SOLITAIRE With the Intention for Thrombectomy (SWIFT) Trial

Presenter: Jeffrey L. Saver

February 08, 2012

Advertisement

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Silent Cerebral Infarcts After Cardiac Catheterization

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Left Atrial Appendage Anatomy: An Anatomical Imaging Review and Implications for Stroke Prevention

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Minimizing and Managing Stroke Risks

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

New Oral Anticoagulants for Stroke Prevention

Intra Cranial Cases: Where, When, Who?

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Volumen de Intervenciones Neuroquirúrgicas por Hospital en EE.UU.

Neurointerventional Procedural Volume Per Hospital in United States

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Procedural Factors Associated with PCI-Related Ischemic Stroke

Resultados Primarios del Dispositivo SOLITAIRE With the Intention for Thrombectomy (SWIFT) Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content